Navigation Links
Get the latest on premier science in medical oncology
Date:7/30/2008

>Hyperthermia improves local control of STS where next?

  • Emerging therapies for rare tumors
    • Neuroendocrine tumors, HCC, thyroid cancer, papillary RCC

  • Assessing, reporting and managing the safety of cancer drugs
    • Detecting safety signals
    • The role of pharmacogenetics in predicting and managing toxicity
    • Handling side effects of targeted therapies

  • Integration of targeted therapies with radiation
    • Where we are with radiation modifiers?

  • Unplanned analysis of molecular studies
    • Harmful or safe?

  • Cancer patients
    • Should all receive prophylactically antithrombotic therapy?
    • Dealing with difficult cases in daily clinical practice

  • New developments in myeloma
    • Prognostic factors and the role of novel drugs
    • The status of transplantation

  • Glioma
    • From imaging to management

  • Recent progress in immunotherapy
    • Anti cancer vaccines
    • Combining immunotherapy with classical anti-cancer therapy

  • Advanced prostate cancer
    • The changing face of hormonal therapy
    • Diabetes and cardiovascular disease in prostate cancer survivors

  • Latest on oncology in developing countries
    • Cancer burden and the role of prevention
    • Balancing costs and benefits in cancer therapy and prevention

  • Drug development
    • How to recognize a promising drug: The role of clinical and biological endpoints
    • The role of regulatory bodies in the drug approval process

    The Highlights of the day session: summary sessions of topics from the preceding day aiming to give an overview of the most interesting and important points to emerge from previous sessions.

    Late-breaking abstracts: oral sessions to present latest research studies with new research findings

    Controversy sessions will create lively discussions on hot topics.

    The 7t
    '/>"/>


  • Contact: Vanessa Pavinato
    media@esmo.org
    41-919-731-907
    European Society for Medical Oncology
    Source:Eurekalert

    Page: 1 2 3 4

    Related medicine news :

    1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
    2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
    3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
    4. Health psychologists discuss latest research findings
    5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
    6. PA Governor Rendell Announces Latest Nominations and Appointments
    7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
    8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
    9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
    10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
    11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... WA (PRWEB) July 31, 2014 ... family practice provider? Community Health Center of Snohomish ... “ Pediatricians vs. Family Doctors ”. Many adults ... are available to them. Community Health Center hopes ... similarities and differences between the two. , ...
    (Date:7/31/2014)... The shale gas development that has vaulted ... U.S. natural gas production has raised concerns that local ... similar to previous resource extraction experiences in Pennsylvania’s history. ... & Jefferson College’s (W&J) Center for Energy Policy & ... that the gas boom in Pennsylvania is still underway, ...
    (Date:7/31/2014)... OR (PRWEB) July 31, 2014 Sales in ... from 2013 to 2014, according to radio talk show host ... been experiencing rapid growth since 1990. The US economy in ... Kleyne Hour Power of Water radio show, reported this information ... Live Foods, a worldwide manufacturer of organic and natural food ...
    (Date:7/31/2014)... 2014 According to new research ... Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, TVP, ... Global Trends & Forecasts to 2019", defines and ... analysis and forecasting of the market value of ... report also identifies the driving and restraining factors ...
    (Date:7/31/2014)... 31, 2014 Care Communications, Inc., (CARE) ... firm, has received the Elite Award for “Recruitment, Selection ... one of twelve elite awards presented as part of ... Work For” 2014 awards competition. This marks the ... Award in the competition. CARE has also been chosen ...
    Breaking Medicine News(10 mins):Health News:Community Health Center of Snohomish County Reveals the Differences Between Pediatricians and Family Practice Providers 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 2Health News:Pennsylvania’s Shale Gas: Examining the Boom and Bust Cycle 3Health News:Organic Food Industry Grew 12% in 2013-2014 Reports Sharon Kleyne Hour Power of Water Host 2Health News:Organic Food Industry Grew 12% in 2013-2014 Reports Sharon Kleyne Hour Power of Water Host 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3Health News:Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers 2
    ... , , HOFFMAN ESTATES, Ill., July 16 ... of America,s top medical institutions in the annual America,s Best Hospitals list ... magazine. St. Alexius Medical Center was ranked among the top 50 ... , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090716/CG47487 ...
    ... , , CARLSBAD, Calif., July 16 ... and microbial nucleic acid purification, announces the launch of an innovative ... genomic DNA from food cultured microorganisms. , , ... other commercial food kits with its easy-to-use protocol that allows for ...
    ... , , PALO ALTO, Calif., ... has been elected chairman of the company,s Board of Directors. , ... the biotechnology industry, and as the former chairman of Connetics Corporation ... leadership and success to TOPICA, as well as an exceptional knowledge ...
    ... , CHICAGO, July 16 Lexington Health ... services for those needing sub-acute medical and rehabilitative services as ... directors has named Dale Zaletel as the company,s new chief ... held the position of Chief Operating Officer since joining Lexington ...
    ... , Gamers Engage Memory, Attention, Processing Skills ... /PRNewswire-USNewswire/ -- The MS Technology Collaborative has created a ... brain power. The Collaborative, an alliance of Bayer HealthCare Pharmaceuticals, Microsoft, ... a free suite of online cognitive games for the MS community. ...
    ... , , , ... one of the nation,s leading domestic manufacturers of prescription foot ... awarded the prestigious Employer of the Year award, which is ... recognizes private sector employers that provide outstanding employment opportunities and ...
    Cached Medicine News:Health News:St. Alexius Medical Center Named to America's Best Hospitals Rankings 2Health News:MO BIO Laboratories, Inc. Launches PowerFood(TM) Microbial DNA Isolation Kit 2Health News:TOPICA Elects G. Kirk Raab as Chairman of the Board 2Health News:Lexington Health Care Names New Chief Executive Officer 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 2Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 3Health News:Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 4Health News:PAL Health Technologies Wins State-Level Prestigious 'Employer of the Year' Award 2
    (Date:7/30/2014)... YORK and KISSING, Germany ... and distributor of a single use and computer-assisted ("robotic") ... (Homi) Shamir , a worldwide recognized medical device executive, ... Mr. Shamir is a highly respected global ... recent assignment he served as President and Chief Executive ...
    (Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
    (Date:7/30/2014)... -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology ... and education markets, announced today that has been no ... disclosed or, to its knowledge, any other reason to ... "We have noticed unusual price and volume increases for ... Steve Barbee , CEO of DigiPath. "While we ...
    Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
    ... 2011 Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK), a marketing ... through wholesalers and direct to retailers, both in the ... a sale and revenue collection cycle with a major ... products to a Northeast distribution center for delivery to ...
    ... Md., June 27, 2011 Glycotex, Inc., a ... has submitted the final results of the two ... product candidate, GLYC-101 gel, to the clinicaltrials.gov database. ... investigational GLYC-101 on wound closure in patients undergoing ...
    Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 2Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain 3Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 2Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 3Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101 4
    ... TruFit® CB Plugs use OBIs ... a scaffold for tissue repair that ... stable. A patented composite of ... the PolyGraft® material can be fabricated ...
    The TruGraft BGS Granules are to be used in bone void filling of surgically or traumatically created osseous defects....
    ... the first to manufacture a diode pumped ... to announce their newest addition, the VITRA. ... the problem that many doctors face when ... No larger than a shoe box, this ...
    ... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
    Medicine Products: